- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Pérez D, Marulanda M, Sanabria A
Behaviour of Early Thyroglobulin after Total Thyroidectomy for Differentiated Thyroid Cancer
Acta Endo (Buc) 2016, 12 (3): 370-374doi: 10.4183/aeb.2016.370
Context. The objectives of treatment of thyroid
carcinoma include hormonal suppression, radioiodine
ablation and follow-up with serum thyroglobulin (Tg).
Tg levels should not be measured before six weeks postthyroidectomy.
Objective. To describe the behaviour of
early postoperative Tg in patients who underwent total
thyroidectomy and its ability to predict the serum Tg levels
after suppression.
Design. This is a retrospective cohort study.
Subjects and methods. Adult patients who
underwent total thyroidectomy with at least two postoperative
measurements of serum Tg, negative TgAb and concomitant
serum TSH values were included. Tg, TgAb and TSH level
measurements were completed two weeks postoperatively
and during the follow-up period.
Results. Twenty-nine patients fulfilled all criteria.
The median serum Tg level at two weeks after surgery was
3.8 ug/L (0.3 -300) with a serum TSH level of 69.9 mU/L;
11-227. At the two-week measurement, 16 (55%) patients
had serum Tg levels lower than 5 ug/L and 4 patients had
levels between 5-10 μg/L.
Conclusions. Postoperative early serum Tg could
be an alternative to values measured six months after
surgery and could be used as a predictive tool to make earlier
therapeutic decisions.
Keywords: well differentiated thyroid carcinoma, thyroglobulin, follow-up, radioiodine ablation.
Correspondence: Alvaro Sanabria MD, Universidad de Antioquia, Hospital Pablo Tobón Uribe, Carrera 51D No. 62-29. Medellin, Colombia, E-mail: alvarosanabria@gmail.com